Nephros Overview
Valuation check: NEPH's P/E ratio is 21.97, below the Healthcare sector average of 77.98.
Get informed when a big investor buys or sells
+ Follow21.97
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, NEPH shows a P/E ratio of 21.97. That is below the Healthcare sector average of 77.98. Scroll down for historical charts and peer comparison views.
The Healthcare sector average P/E ratio is about 77.98. Nephros is at 21.97, which is lower that average. That is roughly 71.8% below the sector mean. Use the comparison chart on this page to see how NEPH stacks up against individual peers as well.
Investors watch NEPH's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Nephros's latest reading is 21.97. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has Nephros's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently 21.97) with ownership activity and broader fundamentals.
The Healthcare average P/E ratio is about 77.98, while NEPH is at 21.97. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
